Dain Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Dain Lee has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Eun Jeong Won
Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
4 shared publications - Jong Hee Shin
Department of Laboratory Medicine, Green Cross Laboratories, Gwangju, Korea
4 shared publications - Soo Hyun Kim
Department of Laboratory Medicine, Chonnam National University Hwasun Hospital, Hwasun 58128, Republic of Korea
4 shared publications - Ju Hyeon Shin
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 shared publications M.D.
2 shared publicationsM.S.
2 shared publications
Latest Publications
- Open Access
- 1 November 2021
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 41 (6) , 559-567
Disk Diffusion Susceptibility Testing for the Rapid Detection of Fluconazole Resistance in Candida Isolates
Suhak Jeon, M.D., Jong Hee Shin, M.D., Ph.D., Ha Jin Lim, M.D., Min Ji Choi, Ph.D., Seung A Byun, M.S., Dain Lee, M.S., Seung Yeob Lee, M.D., Eun Jeong Won, M.D., Soo Hyun Kim, M.D., and Myung Geun Shin, M.D.. Ann Lab Med 2021;41:559-67. https://doi.org/10.3343/alm.2021.41.6.559
- 1 November 2021
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 41 (6) , 559-567
Open AccessDisk Diffusion Susceptibility Testing for the Rapid Detection of Fluconazole Resistance in Candida Isolates
Suhak Jeon, M.D., Jong Hee Shin, M.D., Ph.D., Ha Jin Lim, M.D., Min Ji Choi, Ph.D., Seung A Byun, M.S., Dain Lee, M.S., Seung Yeob Lee, M.D., Eun Jeong Won, M.D., Soo Hyun Kim, M.D., and Myung Geun Shin, M.D.. Ann Lab Med 2021;41:559-67. https://doi.org/10.3343/alm.2021.41.6.559
- Open Access
- 1 March 2021
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 41 (2) , 214-220
Performance Evaluation of VITEK MS for the Identification of a Wide Spectrum of Clinically Relevant Filamentous Fungi Using a Korean Collection
Ju Hyeon Shin, M.D., Soo Hyun Kim, M.D., Dain Lee, M.S., Seung Yeob Lee, M.D., Sejong Chun, M.D., Jun Hyung Lee, M.D., Eun Jeong Won, M.D., Hyun Jung Choi, M.D., Hyun Woo Choi, M.D., Seung Jung Kee, M.D., Myung Geun Shin, M.D., and Jong Hee Shin, M.D.. Ann Lab Med 2021;41:214-20. https://doi.org/10.3343/alm.2021.41.2.214
- 1 March 2021
- Published by Annals of Laboratory Medicine in Annals of Laboratory Medicine
- Vol. 41 (2) , 214-220
Open AccessPerformance Evaluation of VITEK MS for the Identification of a Wide Spectrum of Clinically Relevant Filamentous Fungi Using a Korean Collection
Ju Hyeon Shin, M.D., Soo Hyun Kim, M.D., Dain Lee, M.S., Seung Yeob Lee, M.D., Sejong Chun, M.D., Jun Hyung Lee, M.D., Eun Jeong Won, M.D., Hyun Jung Choi, M.D., Hyun Woo Choi, M.D., Seung Jung Kee, M.D., Myung Geun Shin, M.D., and Jong Hee Shin, M.D.. Ann Lab Med 2021;41:214-20. https://doi.org/10.3343/alm.2021.41.2.214
- Open Access
- 31 March 2020
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 10-16
A Multicenter Study of Antifungal Use and Species Distribution and Antifungal usceptibilities of Candida Isolates in South Korea
Background: Candidiasis control should include monitoring the epidemiology and resistance to various antifungal agents. In this study, the researchers investigated the Candida species recovered from clinical specimens at particular geographic areas or hospitals. Objective: The present study is geared toward the evaluation of antifungal drug usage at Korean hospitals in 2016. It is also essential that species distribution and antifungal susceptibilities of Candida isolates should be looked into to provide important data that can help devise therapeutic strategies to control the disease. Methods: Systemic antifungal agent usage over a one-year period was investigated at 10 Korean hospitals. Identification and antifungal susceptibility tests were performed on clinical isolates of the Candida species, which were collected over a three-month period. Results: The total antifungal usage in each hospital ranged from 7.7 to 158.9 defined daily doses (DDDs) per 1,000 patient days. Fluconazole was most commonly used (37.1%), followed by amphotericin B (30.6%), itraconazole (9.7%), echinocandins (8.8%), voriconazole (7.5%), and posaconazole (6.3%), respectively. Among 274 Candida isolates, C. albicans was the most frequently recovered (51.1%), followed by C. glabrata (15.7%), C. tropicalis (15.0%), and C. parapsilosis (13.5%), respectively. Through the application of either species-specific clinical breakpoints or epidemiological cutoff values to Candida isolates, the non-susceptibility rates to fluconazole, voriconazole, amphotericin B, and micafungin were found in 20.7%, 5.6%, 0%, and 0% of isolates, respectively. Conclusion: This nationwide multicenter study showed that total antifungal use varied considerably according to each hospital. Non-susceptibility to fluconazole should be further monitored, considering the drug's frequent use in Korea.
- 31 March 2020
- Published by Korean Society for Medical Mycology in Korean Journal of Medical Mycology
- p. 10-16
Open AccessA Multicenter Study of Antifungal Use and Species Distribution and Antifungal usceptibilities of Candida Isolates in South Korea
Background: Candidiasis control should include monitoring the epidemiology and resistance to various antifungal agents. In this study, the researchers investigated the Candida species recovered from clinical specimens at particular geographic areas or hospitals. Objective: The present study is geared toward the evaluation of antifungal drug usage at Korean hospitals in 2016. It is also essential that species distribution and antifungal susceptibilities of Candida isolates should be looked into to provide important data that can help devise therapeutic strategies to control the disease. Methods: Systemic antifungal agent usage over a one-year period was investigated at 10 Korean hospitals. Identification and antifungal susceptibility tests were performed on clinical isolates of the Candida species, which were collected over a three-month period. Results: The total antifungal usage in each hospital ranged from 7.7 to 158.9 defined daily doses (DDDs) per 1,000 patient days. Fluconazole was most commonly used (37.1%), followed by amphotericin B (30.6%), itraconazole (9.7%), echinocandins (8.8%), voriconazole (7.5%), and posaconazole (6.3%), respectively. Among 274 Candida isolates, C. albicans was the most frequently recovered (51.1%), followed by C. glabrata (15.7%), C. tropicalis (15.0%), and C. parapsilosis (13.5%), respectively. Through the application of either species-specific clinical breakpoints or epidemiological cutoff values to Candida isolates, the non-susceptibility rates to fluconazole, voriconazole, amphotericin B, and micafungin were found in 20.7%, 5.6%, 0%, and 0% of isolates, respectively. Conclusion: This nationwide multicenter study showed that total antifungal use varied considerably according to each hospital. Non-susceptibility to fluconazole should be further monitored, considering the drug's frequent use in Korea.
- Open Access
- 3 March 2020
- Published by Taylor & Francis in Mycobiology
- Vol. 48 (2) , 148-152
Antifungal Susceptibility Tests and the cyp51 Mutant Strains among Clinical Aspergillus fumigatus Isolates from Korean Multicenters
We investigated the antifungal susceptibilities and the cyp51 mutant strains among Aspergillus fumigatus clinical isolates obtained from 10 university hospitals in Korea. Of the 84 isolates examined, two itraconazole-resistant isolates were found with no amino acid substitution in the cyp51A/cyp51B genes. However, 19 (23.2%) azole-susceptible isolates harbored amino acid substitutions: Nine isolates harbored one to five mutations in cyp51A with high polymorphism, and 11 isolates exhibited the same Q42L mutation in cyp51B. Overall, a low azole resistance rate and high frequency of cyp51A/cyp51B amino acid substitutions were observed in the azole-susceptible A. fumigatus isolates in Korea.
- 3 March 2020
- Published by Taylor & Francis in Mycobiology
- Vol. 48 (2) , 148-152
Open AccessAntifungal Susceptibility Tests and the cyp51 Mutant Strains among Clinical Aspergillus fumigatus Isolates from Korean Multicenters
We investigated the antifungal susceptibilities and the cyp51 mutant strains among Aspergillus fumigatus clinical isolates obtained from 10 university hospitals in Korea. Of the 84 isolates examined, two itraconazole-resistant isolates were found with no amino acid substitution in the cyp51A/cyp51B genes. However, 19 (23.2%) azole-susceptible isolates harbored amino acid substitutions: Nine isolates harbored one to five mutations in cyp51A with high polymorphism, and 11 isolates exhibited the same Q42L mutation in cyp51B. Overall, a low azole resistance rate and high frequency of cyp51A/cyp51B amino acid substitutions were observed in the azole-susceptible A. fumigatus isolates in Korea.